Access
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
Research
Nature Biotechnology 18, 1185–1190 (1 November 2000) | doi:10.1038/81183
Enhancement of tumor necrosis factor |[alpha]| antitumor immunotherapeutic properties by targeted delivery to aminopeptidase N (CD13)
&
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
